Peptide substrates for Rho-Associated kinase 2 (Rho-Kinase 2/ROCK2)

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Kang, Jeong Hun ^a   Asai, Daisuke ^b   Tsuchiya, Akira ^c   Mori, Takeshi ^c   Niidome, Takuro ^c   Katayama, Yoshiki ^c  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE P 32; ARGINYLALANYLLYSYLTYROSYLLYSYLTHREONYLLEUCYLARGINYLGLUTAMYLISOLEUCYLARGININE; CYCLIC AMP DEPENDENT PROTEIN KINASE; LYSYLALANYLASPARTYLARGINYLLYSYLLYSYLARGINYLTYROSYLVALYLVALYLGLYCYLASPARAGINYLPROLYLTYROSYLTRYPTOPHANYLMETHIONINE; LYSYLPROLYLALANYLARGINYLLYSYLLYSYLARGINYLVALYLTHREONYLVALYLVALYLGLYCYLASPARAGINYLPROLYLTYROSYLTRYPTOPHANYLMETHIONINE; LYSYLSERYLALANYLARGINYLLYSYLLYSYLARGINYLTYROSYLVALYLVALYLGLYCYLASPARAGINYLPROLYLVALYLTRYPTOPHANYLMETHIONINE; LYSYLSERYLASPARTYLARGINYLLYSYLLYSYLARGINYLTYROSYLTHREONYLVALYLVALYLGLYCYLASPARAGINYLPROLYLTYROSYLTRYPTOPHANYLMETHIONINE; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE DERIVATIVE; PROTEIN KINASE C ALPHA; RADIOISOTOPE; RHO KINASE; RHO KINASE 2; UNCLASSIFIED DRUG; AMINO ACID; PEPTIDE;

ARTICLE; BINDING AFFINITY; COUNTS PER MINUTE; ENZYME SUBSTRATE; ISOTOPE LABELING; PEPTIDE SYNTHESIS; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RADIOACTIVITY; AMINO ACID SEQUENCE; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; KINETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION;

AMINO ACID SEQUENCE; AMINO ACIDS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; RADIOACTIVITY; RHO-ASSOCIATED KINASES; SUBSTRATE SPECIFICITY;

EID: 79960764775     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022699     Document Type: Article

References (50)

1. Ghoreschi K, Laurence A, O'Shea J, (2009) Selectivity and therapeutic inhibition of kinases: to be or not to be? Nat Immunol 10: 356-360.
2. Kemp BE, Bylund DB, Huang TS, Krebs EG, (1975) Substrate specificity of the cyclic AMP-dependent protein kinase Proc. Natl Acad Sci USA 72: 3448-3452.
3. Cheng HC, Matsuura I, Wang JH, (1993) In vitro substrate specificity of protein tyrosine kinases. Mol Cell Biochem 127-128: 103-12.
4. Kang JH, Asai D, Yamada S, Toita R, Oishi J, et al. (2008) A short peptide is a protein kinase C (PKC)α-specific substrate. Proteomics 8: 2006-2011.
5. Kaibuchi K, Kuroda S, Amano M, (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68: 459-486.
6. Amano M, Fukata Y, Kaibuchi K, (2000) Regulation and functions of Rho-associated kinase. Exp Cell Res 261: 44-51.
7. Loirand G, Guérin P, Pacaud P, (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98: 322-334.
8. Oka M, Fagan KA, Jones PL, McMurtry IF, (2008) Terapeutic poteintial of RhoA/Rho kinase inhibitors in pulmonary hypertension. Br J Pharmacol 155: 444-454.
9. Zhou Q, Liao JK, (2009) Rho kinase: an important medicator of atherosclerosis and vascular disease. Curr Pharm Des 15: 3108-3115.
10. Narumiya S, Tanji M, Ishizaki T, (2009) Rho signaling, ROCK and mDai1, in transformation, metastasis and invasion. Cancer Metastasis Rev 28: 65-76.
11. Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, et al. (2008) Phosphorylation caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res 68: 8210-8220.
12. Shin HK, Salomone S, Ayata C, (2008) Targeting cerebrovascular Rho-kinase in stroke. Expert Opin Ther Targets 12: 1547-1564.
13. Mueller BK, Mack H, Teusch N, (2005) Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 4: 387-398.
14. Kubo T, Yamashita T, (2007) Rho-ROCK inhibitors for the treatment of CNS injury. Recent Pat CNS Drug Discov 2: 173-179.
15. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, et al. (1996) ROCK-1 and ROCK-2, two isoforms of Rho-associated coiled-coil forming protein serine/theronine kinase in mice. FEBS Lett 392: 189-193.
16. Kaneko T, Amano M, Maeda A, Goto H, Takahashi K, et al. (2000) Identification of calponin as a novel substrate of Rho-kinase. Biochem Biophy Res Commun 273: 110-116.
17. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, et al. (2000) Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 275: 3577-3582.
18. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka Y, et al. (1999) Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol 145: 347-361.
19. Goto H, Kosako H, Tanabe K, Yanagida K, Maki M, et al. (1998) Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis. J Biol Chem 273: 11728-11736.
20. Hashimoto R, Nakamura Y, Komai S, Kashiwagi Y, Tamura K, et al. (2000) Site-specific phosphorylation of neurofilament-L is mediated by calcium/calmodulin-dependent protein kinase II in the apical dendrites during long-term potentiation. J Neurochem 75: 373-382.
21. Kosako H, Amano M, Yanagida M, Tanabe K, Nishi Y, et al. (1997) Phosphorylation of glial fibrillary acidic protein at the same sites by cleavage furrow kinase and Rho-associated kinase. J Biol Chem 272: 10333-10336.
22. Arimura N, Inagaki N, Chihara K, Menager C, Nakamura N, et al. (2000) Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem 275: 23973-23980.
23. Amano M, Kaneko T, Maeda A, Nakayama M, Ito M, et al. (2003) Identification of Tau and MAP2 as novel substrates of Rho-kinase and myosin phosphatase. J Neurochem 87: 780-790.
24. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, et al. (1998) Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140: 647-657.
25. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, et al. (1999) Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 147: 1023-1037.
26. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, et al. (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249.
27. Sasaki Y, (2003) New aspects of neurotransmitter release and exocytosis: Rho-kinase-dependent myristoylated alanine-rich C-kinase substrate phosphorylation and regulation of neurofilament structure in neuronal cells. J Pharmacol Sci 93: 35-40.
28. Nagumo H, Ikenoya M, Sakurada K, Furuya K, Ikuhara T, et al. (2001) Rho-associated kinase phosphorylates MARCKS in human neuronal cells. Biochem Biophys Res Commun 280: 605-609.
29. Riento K, Totty N, Villalonga P, Garg R, Guasch R, et al. (2005) RhoE function is regulated by ROCK 1-mediated phosphorylation. EMBO J 24: 1170-1180.
30. Hagerty L, Weitzel DH, Chambers J, Fortner CN, Brush MH, et al. (2007) ROCK1 phosphorylates and activates Zipper-interacting protein kinase. J Biol Chem 282: 4884-4893.
31. Sumi T, Matsumoto K, Nakamura T, (2001) Specific activation of LIM kinase 2 via phosphorylation of Threonine 505 by ROKC, a Rho-dependent protein kinase. J Biol Chem 276: 670-676.
32. Kaneko T, Maeda A, Takefuji M, Aoyama H, Nakayama M, et al. (2005) Rho medicates endocytosis of epidermal growth factor receptor through phosphorylatin of endophilin A1 by Rho-kinase. Genes Cells 10: 973-987.
33. Kang JH, Jiang Y, Toita R, Oishi J, Kawamura K, et al. (2007) Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ROK) substrates by protein kinases A and C. Biochimie 89: 39-47.
34. Kemp BE, Graves DJ, Benjamini E, Krebs EG, (1977) Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem 14: 4888-4894.
35. Rearson RB, Kemp RE, (1988) Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. In: Sefton BM, Hunter T, editors. Protein phosphorylation San Diego, CA Academic Press pp. 65-83.
36. Hug H, Sarre TF, (1993) Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 291: 329-343.
37. Davis RJ, (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556.
38. Hofmann J, (1997) The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 11: 649-669.
39. Nishikawa K, Sawasdikosol S, Fruman DA, Lai J, Songyang Z, et al. (2000) A peptide library approach identifies a specific inhibitor for the ZAP-70 protein tyrosine kinase. Mol Cell 6: 969-974.
40. Jain MK, Rogers J, (1989) Substrate specificity for interfacial catalysis by phospholipase A2 in the scooting mode. Biochem Biophys Acta 1003: 91-97.
41. Koivunen P, Hirsilä M, Kivirikko KI, Myllyharju J, (2006) The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor proly 4-hydroxylases. J Biol Chem 281: 28712-28720.
42. House C, Kemp BE, (1990) Protein kinase C psudosubstrate prototope: sturcture-function relationships. Cell Signa 2: 187-190.
43. Madigan JP, Bodemann BO, Brady DC, Dewar BJ, Keller PJ, et al. (2009) Regultaion of Rnd3 localization and function by protein kinase Cα-mediated phosphorylation. Biochem J 424: 153-161.
44. Somlyo AP, Somlyo AV, (2003) Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358.
45. Patil SB, Bitar KN, (2006) RhoA- and PKC-α-mediated phosphorylation of MYPT and its association with HSP27 in colonic smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 290: G83-G95.
46. Murthy KS, (2006) Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68: 345-374.
47. Leemhuis J, Boutillier S, Schmidt G, Meyer DK, (2002) The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase. J Pharmacol Exp Therap 300: 1000-1007.
48. Liu Y, Suzuki YJ, Day RM, Fanburg BL, (2004) Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Circ Res 95: 579-586.
49. Hong SY, Jeon YM, Lee HJ, Kim JG, Baek JA, et al. (2010) Activation of RhoA and FAK induces ERK-medicated osteopontin expression in mechanical force-subjected periodontal ligament fibroblasts. Mol Cell Biochem 335: 263-272.
50. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M, (2009) Rho/ROCK amd MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res 29: 119-124.